Blood cancers, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial was looking at giving R-CHOP chemotherapy with bevacizumab to treat diffuse large B cell lymphoma. This trial was supported by Cancer Research UK.
Recruitment start: 18 August 2008
Recruitment end: 2 June 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof David Cunningham
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Institute of Cancer Research (ICR)
National Institute for Health Research Cancer Research Network (NCRN)
Roche
The Royal Marsden NHS Foundation Trust
This is Cancer Research UK trial number CRUK/08/029.
Last reviewed: 14 October 2014
CRUK internal database number: 3150